Bank of America reported strong net interest income (NII) growth of 9% year-over-year in the first half of 2026, reaching $31.7 billion with Q2 hitting a record $16 billion. The growth was driven by solid loan and deposit expansion, favorable asset repricing, and improved net interest yield. Management expects 2026 NII growth near the upper end of its 6-8% guidance. BAC shares have outperformed the industry with a 25.1% gain over six months, though the stock trades below industry valuation multiples at 2.20X price-to-tangible book.

Bank of America is leveraging AI, digital adoption, and branch optimization to improve operating leverage, with Erica surpassing 3.2 billion interactions and plans for 150+ new financial centers by 2027. While the bank shows strong revenue growth, improving earnings outlook, and industry-leading deposit franchise, near-term expense pressures and elevated cost growth remain concerns. The stock is rated a Hold despite long-term efficiency potential.

JPMorgan Chase announced a $750 billion housing investment commitment through 2035, aiming to build or preserve 1 million affordable housing units and provide financing to 500,000 homebuyers. This represents a 40% increase from the previous decade and positions JPMorgan as a major player in addressing the U.S. housing shortage and affordability crisis. Other major banks including Wells Fargo, Citigroup, and Bank of America have announced similar housing initiatives.

Uranium Energy Corp's stock has rallied over 400% in the past five years driven by renewed interest in nuclear energy. The Texas-based uranium extraction company could nearly double over the next five years if it matches analyst estimates for 57% revenue CAGR through 2028 and trades at 25x adjusted EBITDA by 2031, though it currently trades at a premium valuation of 60x next year's adjusted EBITDA.

Attovia Therapeutics, a clinical-stage biopharmaceutical company, priced its IPO at $17 per share, raising $289 million from 17 million shares. The company will begin trading on Nasdaq under ticker 'ATTO' on August 5, 2026. Attovia is developing biotherapeutics for immune-mediated diseases using its proprietary ATTOBODY platform, with lead programs targeting chronic pruritic diseases, atopic dermatitis, and inflammatory bowel disease.

A $93 million affordable housing development called Chapanoke has closed in Raleigh, NC, delivering 200 units for households earning 30-70% of Area Median Income. The project is a public-private partnership between Harmony Housing Affordable Development Inc., Gilbane Development, and F7 International Development, with financing from Greystone Real Estate Capital, Greystone Housing Impact Investors LP, Citi Community Capital, Wake County, and the City of Raleigh. Construction is expected to complete in early 2028.

Big bank Q2 2026 earnings reveal that U.S. consumers remain financially healthy despite economic headwinds from inflation and high oil prices. Key credit metrics from Bank of America, Wells Fargo, JPMorgan Chase, and Citigroup show improving or stable charge-off and non-performing loan ratios, suggesting consumers are managing debt well and recession fears may be overstated.

Micron stock fell 5.7% Friday despite bullish semiconductor news. Citigroup called the sector sell-off a buying opportunity, citing strong AI and data center demand for memory chips. Intel also reported better-than-expected earnings with 25% revenue growth. However, investors sold Micron shares anyway, seemingly misreading the positive industry developments.

S&P 500 earnings season shows strong performance with major banks beating expectations, though IBM missed due to data center competition. Energy, technology, and semiconductors are leading earnings growth. Positive analyst revisions suggest stronger underlying earnings ahead. Taiwan Semiconductor Manufacturing reported record June sales of $13.99 billion, signaling strong AI and semiconductor momentum. Cooling inflation data with June CPI declining 0.4% reduces Fed rate hike expectations.

Five major U.S. banks—JPMorgan Chase, Wells Fargo, Citigroup, Goldman Sachs, and Bank of America—report Q2 earnings on Tuesday. With the Federal Reserve maintaining elevated interest rates, net interest income (NII) is the key metric to watch. Investors should also monitor credit-loss provisions to assess consumer health and investment banking activity for signs of broader market recovery.

JPMorgan and Citigroup are set to report Q2 2026 earnings on July 14th. JPMorgan is expected to deliver solid results with 29% EPS growth and 12% revenue growth, supported by strong capital markets activity and aggressive share buybacks. Citigroup is anticipated to report 40% EPS growth and 10% revenue growth. Both banks show healthy credit conditions and significant capital return programs, though analyst concerns persist about the sustainability of capital markets tailwinds.

Holtec Nuclear Corporation has filed a registration statement on Form S-1 with the SEC for a proposed initial public offering of its Class A common stock on Nasdaq under the symbol 'HNUC'. The company, headquartered in Camden, N.J., is a multinational technology company focused on nuclear power generation and clean energy solutions, including the development of the SMR-300 advanced small modular reactor and the refurbishment of the Palisades nuclear power plant in Michigan.